Serum biomarkers identified by proteomics and measured by commercially available assays associate with lung function during clinically stable states

Published in Journal of Cystic Fibrosis, 2021

Recommended citation: Szczesniak RD, Heltshe S, Siefert M, Gecili E, Clancy JP, Sagel S, Ziady A. (2021). " Serum biomarkers identified by proteomics and measured by commercially available assays associate with lung function during clinically stable states." Journal of Cystic Fibrosis 20 (2021): S274 – S276.